Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Bone Biologics Corp. (BBLG) had Return on Investments of -11.23% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-0.74M |
|
-- |
|
-- |
|
$0.75M |
|
$-0.75M |
|
$0.01M |
|
$-0.74M |
|
$-0.74M |
|
$-0.74M |
|
$-0.74M |
|
$-0.74M |
|
$-0.74M |
|
$-0.75M |
|
$-0.75M |
|
0.56M |
|
0.56M |
|
$-1.33 |
|
$-1.33 |
|
| Balance Sheet Financials | |
$7.00M |
|
-- |
|
-- |
|
$7.00M |
|
$0.41M |
|
-- |
|
-- |
|
$0.41M |
|
$6.60M |
|
$6.60M |
|
$6.60M |
|
1.69M |
|
| Cash Flow Statement Financials | |
$-1.39M |
|
-- |
|
$4.70M |
|
$3.33M |
|
$6.64M |
|
$3.32M |
|
$0.12M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
17.24 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.39M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-11.23% |
|
-11.23% |
|
-10.58% |
|
|
Return on Investments |
-11.23% |
$3.91 |
|
$-2.48 |
|
$-2.48 |
|